neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record

Share Article

The neXante Skin Cancer Surveillance Support Suite comprises applications titled xBCC Skin, xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of the skin. Each application has neXante's DermTracker, a customized electronic health record that not only tracks and stores images of the skin, but also allows for recording the diagnosis, pathology, and treatment of each skin lesion.

Bright 50, a new smartphone healthcare application developer, announced the immediate availability of its neXante Skin Cancer Surveillance Support Suite for Apple Inc's iPhone. With this announcement, consumers and patients gain access to clinical disease modules with the latest clinical studies and consensus medical guidelines integrated with specialized tools to track and monitor a specific disease state.

Skin cancer is the most common cancer in the world, outnumbering all other types of cancer combined. The number of new cases of skin cancer is also rising rapidly, afflicting over 2 million people a year in the United States alone. Of all the cancers, skin cancer has the greatest potential of being cured provided it is recognized and treated early. However, only with effective tools and knowledge can any disease be prevented, recognized, and treated.

The iPhone provides unique benefits and opportunities with its exceptional multimedia capabilities and computational power. Bright 50 has leveraged the capabilities of the iPhone to use as a platform for interactive customizable personalized health tools and records.

The neXante Skin Cancer Surveillance Support Suite comprises applications titled xBCC Skin, xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of the skin. Each application has neXante's DermTracker, a customized electronic health record that not only tracks and stores images of the skin, but also allows for recording the diagnosis, pathology, and treatment of each skin lesion.

neXante medical resources enable healthcare consumers to improve the quality of care, reduce costs, increase efficiencies and reduce medical errors while actively engaging individuals to improve their personal health.

About Bright 50

Bright 50 is a healthcare application developer for mobile devices. Bright 50's neXante service educates, enables, and empowers healthcare consumers to become engaged in their health by delivering medical information in an intuitive and interactive manner that supports individual engagement. Bright 50 is a privately held company headquartered in Redmond, Washington. For more information on neXante services go to http://www.nexante.com/. Media contact:pr(at)nexante(dot)com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

On Lee